北京诚济制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
55
NMPA:55
Drug Approvals
Compound Sodium Picosulfate Granules
- Product Name
- 复方匹可硫酸钠颗粒
- Approval Number
- 国药准字H20249419
- Approval Date
- Nov 22, 2024
NMPA
Polyethylene Glycol Electrolytes Powder（Ⅲ）
- Product Name
- 复方聚乙二醇电解质散(Ⅲ)
- Approval Number
- 国药准字H20244990
- Approval Date
- Sep 26, 2024
NMPA
Potassium Chloride Granules
- Product Name
- 氯化钾颗粒
- Approval Number
- 国药准字H20244501
- Approval Date
- Jul 30, 2024
NMPA
Potassium Chloride Granules
- Product Name
- 氯化钾颗粒
- Approval Number
- 国药准字H20244502
- Approval Date
- Jul 30, 2024
NMPA
Potassium Chloride Oral Solution
- Product Name
- 氯化钾口服溶液
- Approval Number
- 国药准字H20243603
- Approval Date
- Apr 24, 2024
NMPA
Levocarnitine Oral Solution
- Product Name
- 左卡尼汀口服溶液
- Approval Number
- 国药准字H20193098
- Approval Date
- Mar 21, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found